News in brief

Kaneka receives Canadian NPN for Floradapt Cardio

By Stephen Daniells

- Last updated on GMT

© Getty Images / Moussa81
© Getty Images / Moussa81
Health Canada’s Natural Health Products Directorate (NHPD) has issued a Class III approval for Kaneka’s Floradapt Cardio probiotic.

Identified by the Natural Product Number (NPN) 80096187, Floradapt Cardio​ contains Lactobacillus plantarum​ KABP-011, KABP-012, and KABP-013.

“With this approval from Health Canada, we are providing dietary supplement companies an innovative way to engage the cardiovascular market,”​ said Mike Kolifrath, Vice President, Sales and Marketing of the Probiotics Division at Kaneka.

The product’s NPN allows for the following claims in Canada (the claims are not valid for the USA):

• Helps to reduce levels of total cholesterol in men and women with hypercholesterolemia.

• Helps support healthy cholesterol level in hypercholesterolemic patients

• Supports cardiovascular health by contributing to healthy serum cholesterol in hypercholesterolemic patients

• Helps support intestinal / gastrointestinal health

• Could promote a favorable gut flora

• Source of probiotics

Related news

Related products

show more

Embrace the Biotic Edge from Gut to Skin

Embrace the Biotic Edge from Gut to Skin

Content provided by CJ BIO | 08-Nov-2024 | White Paper

Searching for ways to stand out in the market? Dive into our report that analyzes the evolution of the biotics market to identify the key elements driving...

Your Product Innovation Begins Here: Booth 4055

Your Product Innovation Begins Here: Booth 4055

Content provided by Effepharm Ltd | 22-Oct-2024 | Product Brochure

EffePharm will showcase innovative anti-aging solutions, featuring UthPeak™, world’s first self-GRAS approved NMNH, which boosts NAD+ levels by 10X. UthPeak™...

Related suppliers

Follow us

Products

View more

Webinars